Todas las investigaciones
AutorizadoExploratorio terapéutico (Fase II)Intervencionista

Randomized, observer-blind, placebo-controlled, four Parallel Group, Clinical Trial for exploring the Efficacy and Tolerability of two different strengths ketotifen nasal spray (Ketotifen 0.025 mcg/ml and 0.050 mcg/ml) vs sodium cromoglicate nasal spray 2% in Patients with Rhinitis

Rhinitis causes troublesome nasal symptoms such as sneezing, congestion, an itchy nose, and a constant runny nose, often due to allergies like hay fever. This study looks at whether a nasal spray containing ketotifen can provide effective relief. Ketotifen works by blocking histamine, a natural substance the body releases during an allergic reaction. Participants will be placed into one of four groups to receive either a low strength of ketotifen, a higher strength of ketotifen, an established allergy nasal spray (sodium cromoglicate), or a dummy spray (placebo) with no active medicine. The trial lasts 12 weeks. During this time, doctors will monitor how well your symptoms improve and check for any side effects. The results will help doctors understand whether ketotifen nasal spray is a safe and helpful new treatment option for people living with rhinitis.

De un vistazo

Estado
Autorizado
Fase
Exploratorio terapéutico (Fase II)
Patrocinador
Eudemus Pharmaceuticals Limited
Objetivo de inscripción
120
Inicio
16 Jul 2026

¿De qué trata este estudio?

Rhinitis is a common condition where the inside of your nose becomes inflamed, swollen, and irritated. For many people, it is triggered by airborne allergens such as pollen, house dust mites, or animal fur. Typical symptoms include frequent sneezing, a blocked or runny nose, and an itchy throat or eyes. While many treatments already exist, not everyone gets full relief, which is why researchers continue to look for better options.

This study is testing a medicine called ketotifen, prepared as a nasal spray. Ketotifen is an antihistamine and mast-cell stabiliser, meaning it helps calm the immune cells that trigger allergy symptoms. In this trial, researchers are testing two different strengths of ketotifen to see which works best and whether they cause any bothersome side effects.

To find out how well ketotifen truly works, it needs to be compared against other treatments. Participants will be randomly allocated to receive one of four sprays: a low strength of ketotifen, a higher strength, an existing allergy spray called sodium cromoglicate, or a placebo spray that contains no active medicine. Neither you nor the trial staff observing your symptoms will know which spray you are using, ensuring fair and unbiased results.

Finding new ways to manage rhinitis can make a meaningful difference to quality of life. By taking part, you could help researchers discover whether ketotifen nasal spray offers a reliable, well-tolerated way to keep daily allergy symptoms under control.

Puntos clave

  • Tests whether ketotifen nasal spray effectively relieves symptoms of rhinitis.
  • Compares two strengths of ketotifen against an existing allergy spray and a dummy spray.
  • Open to adults aged 18 and over who experience nasal symptoms like congestion and sneezing.
  • Involves daily spray use and clinic visits over a 12-week period.
  • Participation is completely voluntary, and you can leave the study at any time.

¿Quién puede ser elegible?

This study is open to adults aged 18 and over who have been diagnosed with rhinitis or regularly experience bothersome nasal allergy symptoms.

Men and women of any background may be able to join. Because this trial focuses on general adult rhinitis, people from across the adult age spectrum are welcome to enquire.

You might not be eligible if you have certain other medical conditions, severe nasal blockages (such as large nasal polyps), or if you are using specific medications that could interfere with the study results. The clinical team will review your full medical history before you join.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. I am aged 18 or older.
  2. I have been diagnosed with rhinitis or regularly suffer from nasal allergy symptoms.
  3. I am troubled by symptoms such as a runny, blocked, or itchy nose.
  4. I am willing to use a daily nasal spray for 12 weeks.
  5. I can attend regular hospital or clinic check-ups over a 3-month period.
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

Taking part in this study lasts for about 12 weeks. At the start, you will attend a baseline appointment where the study team will check your health, discuss your symptoms, and explain how to use your assigned nasal spray. You will be asked to spray the medicine into your nose each day as directed. Throughout the 12 weeks, you will attend check-up visits, including an important review at 4 weeks and a final visit at 12 weeks. During these visits, doctors will ask you to score your nasal symptoms—such as stuffiness, sneezing, and itching—using simple symptom questionnaires and rating scales. The team will also monitor your overall health to make sure the spray is comfortable and safe for you to use.

Riesgos y beneficios potenciales

You may benefit from receiving close medical monitoring for your rhinitis, and your symptoms might improve during the study. However, there is no guarantee of direct benefit, especially if you are placed in the placebo (dummy spray) group. As with any nasal spray, potential side effects can include temporary stinging, dryness, sneezing, or a mild nosebleed. You are free to leave the trial at any time without giving a reason, and your regular NHS medical care will not be affected.

Ubicaciones (1)

Algunas ubicaciones de los sitios son aproximadas. Estamos mejorando esto — por favor verifique con el equipo de prueba antes de viajar.
  • —
    No verificado
    Greece

Preguntas comunes

What is a placebo spray?

A placebo is a dummy spray that looks identical to the real medicine but contains no active ingredients. It helps scientists confirm that any improvements are genuinely caused by the medicine itself.

Can I choose which nasal spray I receive?

No. A computer assigns you to one of the four treatment groups by chance. This random process ensures the study results are fair and reliable.

Will taking part cost me anything?

No. Study medication, clinic visits, and all trial-related tests are provided free of charge. Some studies also help cover travel expenses.

What if my allergy symptoms get much worse?

Your safety comes first. The study doctors will monitor you closely and can provide guidance or alternative treatments if your symptoms become severe.

Can I stop taking part if I change my mind?

Yes. Joining a clinical trial is entirely voluntary. You can withdraw at any point, and your standard NHS care will continue as normal.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.